Insmed Incorporated (INSM) Revenue by Segment
Insmed revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 30, 2026), Insmed's largest product or service was Brinsupri, with $309.17 million or 73% of revenue. Next: Arikayce (27%).
By region, United States brought in 89% and Non-US brought in 11% of revenue in Q2 fiscal 2026.
By country, UNITED STATES brought in 89% and Non-US brought in 11% of revenue in Q2 fiscal 2026.
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q1 fiscal 2021.
Insmed Incorporated
Revenue breakdown
Fiscal quarters, from company filings
Insmed revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Brinsupri | $309.2M | $207.9M | $28.1M | – | 73% |
| Arikayce | $116.3M | $98.1M | $114.3M | – | 27% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Insmed revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $378.7M | $270.1M | $102.0M | $68.7M | 89% |
| Non-US | $46.7M | $35.9M | $40.3M | $38.7M | 11% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Insmed revenue by country, last 4 quarters
| Country | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| UNITED STATES | $378.7M | $270.1M | $102.0M | $68.7M | 89% |
| Non-US | $46.7M | $35.9M | $40.3M | $38.7M | 11% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
Which product or service makes the most money for Insmed?
Brinsupri: $309.17 million, or 73% of revenue, in Q2 fiscal 2026.
What are Insmed's main products and services?
By revenue in Q2 fiscal 2026: Brinsupri (73%) and Arikayce (27%).
Where does Insmed make its money?
By region in Q2 fiscal 2026: United States (89%) and Non-US (11%).
